The Effect of Gum Olibanum on blood glucose

Phase 2

• Conditions: Type II Diabetic.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT201112078318N1
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Diabetes is a common metabolic disease in the world that has many adverse effects. One of the best criteria for controlling this disease is HbA1c that shows the average of blood glucose in 2-3 past months. Gum Olibanum (from trees of the genus Boswellia) has been traditionally used in the treatment of various diseases such as diabetes. The goal of this study is the comparison of gum olibanum resin extract effect with placebo on the treatment of type 2 diabetes.Inclusion criteria is diabetic patients with FBS=140-200 mg/dl.Exclusion criteria are pregnant and nursing women; People under 18 years old and above 65 years old; cases of intensive diabetic; Using drugs which affect blood glucose like edible and positional Steroid; Diuretics drugs.This study has been designed as double-blined clinical trial on 86 patients with type 2 diabetes.The patients randomly will be divided to interventional and placebo groups.The groups will be treated with Gum olibanum (400 mg cap) and placebo tow times per day for 12 weeks,respectively. At the end of 8 weeks the FBS and HbA1c will be messured.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

Suffering from type II diabetic with fasting blood glucose 140-200 Exclusion criteria: Pregnant and nursing women; People under 18 years old and above 65 years old; In case of intensive diabetic; Using drugs which affect blood glucose like edible and positional Steroid; Diuretics drugs

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FBS level. Timepoint: After 12 Weeks of taking drug. Method of measurement: glucometer.;HbA1c level. Timepoint: After 12 Weeks of taking drug. Method of measurement: Laboratory kit.